Published in Diabetes Res Clin Pract on June 09, 1987
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Therapeutic approaches to bone diseases. Science (2000) 5.60
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry (1992) 4.94
Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry (2000) 4.84
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Osteoblastic cells are involved in osteoclast formation. Endocrinology (1988) 4.37
Modulation of osteoclast differentiation. Endocr Rev (1992) 4.27
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) (1987) 4.02
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int (1981) 3.77
Schizophrenia and the myth of intellectual decline. Am J Psychiatry (1997) 3.76
Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations. Lancet (1995) 3.74
Psychiatric illness in male doctors and controls: an analysis of Scottish hospitals in-patient data. Br J Psychiatry (1977) 3.69
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study. Br J Psychiatry (1996) 3.57
Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet (1993) 3.42
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 3.07
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry (2000) 2.93
A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int (1999) 2.87
Puberty and the onset of psychosis. Schizophr Res (1993) 2.86
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (1989) 2.83
Analgesic nephropathy: clinical syndrome and prognosis. Br Med J (1971) 2.77
Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet (1991) 2.74
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Prenatal exposure to influenza epidemics and risk of mental retardation. Eur Arch Psychiatry Clin Neurosci (1995) 2.67
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. Neuroimage (1995) 2.58
Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry (2000) 2.53
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
The bone density of female twins discordant for tobacco use. N Engl J Med (1994) 2.44
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40
Down syndrome and thyroid function in adults. Lancet (1975) 2.39
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia (2010) 2.35
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med (1984) 2.33
Malignant glaucoma after laser iridotomy. Ophthalmology (1992) 2.28
Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun (1999) 2.28
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry (1997) 2.26
Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26
Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ (2001) 2.22
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Taste genes associated with dental caries. J Dent Res (2010) 2.17
Diabetes and hypertension. Australian Diabetes Society position statement. Med J Aust (1995) 2.14
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev (2006) 2.08
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
The hypercalcemia of malignancy: pathogenesis and management. Metabolism (1982) 2.01
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology (2001) 1.98
Is schizophrenia disappearing? Lancet (1990) 1.98
School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry (1999) 1.97
Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ (1999) 1.96
The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res (2002) 1.95
Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry (1997) 1.94
The impact of molecular genetics on our understanding of the psychoses. Br J Psychiatry (1989) 1.90
Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes. Diabetologia (2011) 1.90
Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88
Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation (1998) 1.87
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry (2000) 1.81
The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophr Res (1997) 1.79
Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol (1997) 1.77
Characteristics and prognosis of alcoholic doctors. Br Med J (1976) 1.77
Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res (1998) 1.77
Alcoholism amongst male doctors in Scotland. Lancet (1976) 1.76
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology (1998) 1.75
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology (1998) 1.75
Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res (1987) 1.73
Appearance of specific colostrum antibodies after clinical infection with Salmonella typhimurium. Br Med J (1974) 1.73
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest (1986) 1.73
Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis (2005) 1.71
Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem (2005) 1.71
Reduced bone mass in daughters of women with osteoporosis. N Engl J Med (1989) 1.70
The Kraepelinian dichotomy: evidence from developmental and neuroimaging studies. J Neuropsychiatry Clin Neurosci (2000) 1.70
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int (1999) 1.69
Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney Int (2006) 1.68
Neurological abnormalities in familial and sporadic schizophrenia. Brain (1998) 1.68
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology (2001) 1.66
The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res (1998) 1.65